Companies / Viking Therapeutics Inc / Activity

Activity — Viking Therapeutics Inc

16 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
First Trust Advisors LP
13F manager
NewCommon stock$3.44M+106K
105,570
0.09% of shares
low
Q1 2026
as of
Marshall Wace, LLP
13F manager
NewCommon stock$2.94M+90K
90,360
0.08% of shares
low
Q4 2025
as of
Alberta Investment Management Corp
13F manager
NewCommon stock$1.24M+35K
35,300
0.03% of shares
low
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
NewCommon stock$1.19M+36K
36,493
0.03% of shares
low
Q1 2026
as of
Blackstone Inc
13F manager
NewCommon stock$1.16M+36K
35,726
0.03% of shares
low
Q4 2025
as of
Sanctuary Advisors, LLC
13F manager
NewCommon stock$1.01M+29K
28,849
0.02% of shares
low
Q1 2026
as of
Prelude Capital Management, LLC
13F manager
NewCommon stock$489.8K+15K
15,051
0.01% of shares
low
Q1 2026
as of
AQR Capital Management, LLC
13F manager
NewCommon stock$390.0K+12K
12,172
0.01% of shares
low
Q1 2026
as of
Water Island Capital LLC
13F manager
NewCommon stock$334.5K+10K
10,280
<0.01% of shares
low
Q1 2026
as of
Amundi
13F manager
NewCommon stock$209.7K+6K
6,443
<0.01% of shares
low
Q3 2024
as of
Danske Bank A/S
13F manager
NewCommon stock$63.3K+1K
1,000
<0.01% of shares
low
Q2 2025
as of
Elevation Point Wealth Partners, LLC
13F manager
NewCommon stock$29.4K+1K
1,110
<0.01% of shares
low
Q4 2025
as of
Danske Bank A/S
13F manager
NewCommon stock$14.1K+400
400
<0.01% of shares
low
Q4 2023
as of
Leonteq Securities AG
13F manager
NewCommon stock$1.9K+100
100
<0.01% of shares
low
Q1 2026
as of
Algert Global LLC
13F manager
NewCommon stock$215+7K
6,620
<0.01% of shares
low
Q1 2026
as of
Bessemer Group Inc
13F manager
NewCommon stock$78+2K
2,400
<0.01% of shares
low
← PrevPage 1 of 1Next →